INBS Overview

Intelligent Bio Solutions Inc. is a medical technology company focused on delivering intelligent, rapid, non-invasive testing solutions. The Company’s active product is the Intelligent Fingerprinting Platform, which consists of a portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its Intelligent Fingerprinting Drug Screening System (the IFP System) is a two-part system that consists of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The IFP System comprises a single-use tamper-evident drug screening cartridge for sample collection and the Intelligent Fingerprinting DSR-Plus portable analysis unit onto which ten fingerprint sweat samples are collected in under a minute before the portable analysis unit provides an on-screen result in under ten minutes.

Wall Street analysts forecast INBS stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for INBS is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Intelligent Bio Solutions Inc revenue for the last quarter amounts to 1.06M USD, increased 45.54

Intelligent Bio Solutions Inc. EPS for the last quarter amounts to -1.80 USD, decreased -59.18

Intelligent Bio Solutions Inc (INBS) has 16 emplpoyees as of May 31 2026.

Today INBS has the market capitalization of 6.15M USD.